Page 94 - Biodegradable Polyesters
P. 94

72  3 Microbial Synthesis of Biodegradable Polyesters: Processes, Products, Applications

                       Escherichia coli. Biotechnol. Bioeng., 109,  81. Parlane, N.A., Wedlock, D.N., Buddle,
                       1101–1108.                       B.M., and Rehm, B.H.A. (2009) Bacte-
                    78. Hooks, D.O., Blatchford, P.A., and Rehm,  rial polyester inclusions engineered to
                       B.H.A. (2013) Bioengineering of bac-  display vaccine candidate antigens for
                       terial polymer inclusions catalyzing  use as a novel class of safe and efficient
                       the synthesis of N-Acetylneuraminic  vaccine delivery agents. Appl. Environ.
                       acid. Appl. Environ. Microbiol., 79,  Microbiol., 75, 7739–7744.
                       3116–3121.                    82. Parlane, N.A.,Grage, K.,Lee,J.W.,
                    79. Atwood, J.A. and Rehm, B.H.A. (2009)  Buddle, B.M., Denis, M., and Rehm,
                       Protein engineering towards biotech-  B.H.A. (2011) Production of a particulate
                       nological production of bifunctional  hepatitis C vaccine candidate by an engi-
                       polyester beads. Biotechnol. Lett., 31,  neered lactococcus lactis strain. Appl.
                       131–127.                         Environ. Microbiol., 77, 8516–8522.
                    80. Chen,S., Parlane, N.A.,Lee,J., Wedlock,  83. Parlane, N.A., Grage, K., Mifune, J.,
                       D.N., Buddle, B.M., and Rehm, B.H.A.  Basaraba, R.J., Wedlock, D.N., Rehm,
                       (2014) New skin test for detection of  B.H.A., and Buddle, B.M. (2012) Vac-
                       bovine tuberculosis on the basis of  cines displaying mycobacterial proteins
                       antigen-displaying polyester inclusions  on biopolyester beads stimulate cellular
                       produced by recombinant Escherichia  immunity and induce protection against
                       coli. Appl. Environ. Microbiol., 80,  tuberculosis. Clin. Vaccine Immunol., 19,
                       2526–2535.                       37–44.
   89   90   91   92   93   94   95   96   97   98   99